Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Shapiro

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
The Journal of Antimicrobial Chemotherapy|February 1, 1988
Enoxacin: in-vitro and animal evaluation as a parenteral and oral agent against hospital bacterial isolatesC L Heifetz, P A Bien, M A Cohen, et al.
Journal of Medicinal Chemistry|April 2, 1993
Quinolone antibacterials containing the new 7-[3-(1-aminoethyl)-1- pyrrolidinyl] side chain: the effects of the 1-aminoethyl moiety and its stereochemical configurations on potency and in vivo efficacyJ M Domagala, S E Hagen, T Joannides, et al.
Journal of Medicinal Chemistry|January 24, 1992
New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic riskJ P Sanchez, A J Bridges, R Bucsh, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1996
Structure-activity relationships of quinolone agents against mycobacteria: effect of structural modifications at the 8 positionT E Renau, J W Gage, J A Dever, et al.
American Journal of Public Health|March 1, 1971
Report of the committee on professional education, 1970J D Porterfield, S J Axelrod, A G Bridge, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Total neoadjuvant therapy in early-onset versus average-onset locally advanced rectal cancer: patient characteristics and tolerance of therapyM L Conces, N Tursun, I Ozgur, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
The Journal of Antimicrobial Chemotherapy|February 1, 1988
Enoxacin: in-vitro and animal evaluation as a parenteral and oral agent against hospital bacterial isolatesC L Heifetz, P A Bien, M A Cohen, et al.
Journal of Medicinal Chemistry|April 2, 1993
Quinolone antibacterials containing the new 7-[3-(1-aminoethyl)-1- pyrrolidinyl] side chain: the effects of the 1-aminoethyl moiety and its stereochemical configurations on potency and in vivo efficacyJ M Domagala, S E Hagen, T Joannides, et al.
Journal of Medicinal Chemistry|January 24, 1992
New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic riskJ P Sanchez, A J Bridges, R Bucsh, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1996
Structure-activity relationships of quinolone agents against mycobacteria: effect of structural modifications at the 8 positionT E Renau, J W Gage, J A Dever, et al.
American Journal of Public Health|March 1, 1971
Report of the committee on professional education, 1970J D Porterfield, S J Axelrod, A G Bridge, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Total neoadjuvant therapy in early-onset versus average-onset locally advanced rectal cancer: patient characteristics and tolerance of therapyM L Conces, N Tursun, I Ozgur, et al.
Pageof 7